New Supply Warning Issued for Hormone Replacement Therapy Products
Women who rely on Hormone Replacement Therapy (HRT) are being urged to stay informed following an official notice regarding the availability of certain medical supplies. As of October 15, 2026, the Department of Health has confirmed that supply chain disruptions are impacting the availability of specific transdermal patches used in menopause management.
For many women navigating menopause, HRT is a vital component of their healthcare regimen. Maintaining consistent access to these medications is essential for managing symptoms and long-term health outcomes. If you or a loved one are concerned about medication access, you can find more resources on our Health section.
Which Products Are Affected?
The Department of Health has identified two specific brands of HRT patches currently experiencing supply shortages:
- Estradot transdermal patches
- FemSeven Conti patches
These products are widely prescribed for the treatment of symptoms associated with menopause. The disruption in supply is part of ongoing challenges within the pharmaceutical supply chain that can occasionally affect specific formulations or delivery methods.
What Should Patients Do Next?
While reports of these shortages have caused concern, health authorities are working to mitigate the impact on patient care. If your pharmacy is unable to fill a prescription for these specific brands, it is recommended that you speak with your GP or a pharmacist as soon as possible.
Medical professionals can often provide advice on therapeutic alternatives or help identify which pharmacies may still have remaining stock. Patients are advised not to abruptly stop their hormone therapy without first consulting a qualified healthcare professional, as sudden changes to medication can affect symptom management.
Understanding Medication Shortages
The pharmaceutical industry occasionally faces fluctuations in stock levels due to manufacturing complexities or global supply chain issues. The Department of Health continues to monitor the situation closely to ensure that patients can continue their treatments with as little disruption as possible. This information, originally detailed in a report by the BBC, underscores the importance of proactive communication between patients, pharmacists, and prescribers.
Summary of Advice
In summary, while the current shortage of Estradot and FemSeven Conti patches is an inconvenience, there are established protocols to help patients secure the care they need. By maintaining open lines of communication with healthcare providers, women can navigate these temporary supply challenges safely. Stay informed through official government health portals and ensure that you check your repeat prescription schedules well in advance during periods of known supply instability.
